Legis Daily

National Commission on Scleroderma and Fibrotic Diseases Act of 2019

USA116th CongressHR-3446| House 
| Updated: 6/25/2019
Peter T. King

Peter T. King

Republican Representative

New York

Cosponsors (46)
Nita M. Lowey (Democratic)Mark Pocan (Democratic)Abigail Davis Spanberger (Democratic)Joyce Beatty (Democratic)Brian Higgins (Democratic)Kathleen M. Rice (Democratic)Sheila Jackson Lee (Democratic)Carolyn B. Maloney (Democratic)Max Rose (Democratic)Eliot L. Engel (Democratic)Andy Levin (Democratic)Suzan K. DelBene (Democratic)Paul Tonko (Democratic)Thomas R. Suozzi (Democratic)Wm. Lacy Clay (Democratic)Haley M. Stevens (Democratic)Adriano Espaillat (Democratic)Harley Rouda (Democratic)Joseph D. Morelle (Democratic)Rodney Davis (Republican)Dean Phillips (Democratic)Anthony Brindisi (Democratic)Pramila Jayapal (Democratic)Denny Heck (Democratic)Antonio Delgado (Democratic)Jamie Raskin (Democratic)Joe Neguse (Democratic)Cynthia Axne (Democratic)James P. McGovern (Democratic)Adam Smith (Democratic)Yvette D. Clarke (Democratic)Rick Larsen (Democratic)Peter Welch (Democratic)Brian K. Fitzpatrick (Republican)Bennie G. Thompson (Democratic)Bill Posey (Republican)Josh Gottheimer (Democratic)Ed Perlmutter (Democratic)Zoe Lofgren (Democratic)Scott R. Tipton (Republican)Jenniffer González-Colón (Republican)Jason Crow (Democratic)Susie Lee (Democratic)Cathy McMorris Rodgers (Republican)Chellie Pingree (Democratic)Mike Levin (Democratic)

Health Subcommittee, Energy and Commerce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
National Commission on Scleroderma and Fibrotic Diseases Act of 2019 This bill temporarily establishes a National Commission on Fibrotic Diseases within the National Institutes of Health that must recommend improvements regarding fibrosis and fibrotic disease research.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Jun 24, 2019
Introduced in House
Jun 24, 2019
Referred to the House Committee on Energy and Commerce.
Jun 25, 2019
Referred to the Subcommittee on Health.
Sep 12, 2019

Latest Companion Bill Action

S 116-2477
Introduced in Senate
  • June 24, 2019
    Introduced in House


  • June 24, 2019
    Referred to the House Committee on Energy and Commerce.


  • June 25, 2019
    Referred to the Subcommittee on Health.


  • September 12, 2019

    Latest Companion Bill Action

    S 116-2477
    Introduced in Senate

Health

Related Bills

  • S 116-2477: National Commission on Scleroderma and Fibrotic Diseases Act of 2019
Advisory bodiesCongressional oversightGovernment studies and investigationsHealth programs administration and fundingHealth promotion and preventive careMedical researchMedical tests and diagnostic methodsMusculoskeletal and skin diseasesOrgan and tissue donation and transplantationResearch administration and fundingResearch and development

National Commission on Scleroderma and Fibrotic Diseases Act of 2019

USA116th CongressHR-3446| House 
| Updated: 6/25/2019
National Commission on Scleroderma and Fibrotic Diseases Act of 2019 This bill temporarily establishes a National Commission on Fibrotic Diseases within the National Institutes of Health that must recommend improvements regarding fibrosis and fibrotic disease research.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Jun 24, 2019
Introduced in House
Jun 24, 2019
Referred to the House Committee on Energy and Commerce.
Jun 25, 2019
Referred to the Subcommittee on Health.
Sep 12, 2019

Latest Companion Bill Action

S 116-2477
Introduced in Senate
  • June 24, 2019
    Introduced in House


  • June 24, 2019
    Referred to the House Committee on Energy and Commerce.


  • June 25, 2019
    Referred to the Subcommittee on Health.


  • September 12, 2019

    Latest Companion Bill Action

    S 116-2477
    Introduced in Senate
Peter T. King

Peter T. King

Republican Representative

New York

Cosponsors (46)
Nita M. Lowey (Democratic)Mark Pocan (Democratic)Abigail Davis Spanberger (Democratic)Joyce Beatty (Democratic)Brian Higgins (Democratic)Kathleen M. Rice (Democratic)Sheila Jackson Lee (Democratic)Carolyn B. Maloney (Democratic)Max Rose (Democratic)Eliot L. Engel (Democratic)Andy Levin (Democratic)Suzan K. DelBene (Democratic)Paul Tonko (Democratic)Thomas R. Suozzi (Democratic)Wm. Lacy Clay (Democratic)Haley M. Stevens (Democratic)Adriano Espaillat (Democratic)Harley Rouda (Democratic)Joseph D. Morelle (Democratic)Rodney Davis (Republican)Dean Phillips (Democratic)Anthony Brindisi (Democratic)Pramila Jayapal (Democratic)Denny Heck (Democratic)Antonio Delgado (Democratic)Jamie Raskin (Democratic)Joe Neguse (Democratic)Cynthia Axne (Democratic)James P. McGovern (Democratic)Adam Smith (Democratic)Yvette D. Clarke (Democratic)Rick Larsen (Democratic)Peter Welch (Democratic)Brian K. Fitzpatrick (Republican)Bennie G. Thompson (Democratic)Bill Posey (Republican)Josh Gottheimer (Democratic)Ed Perlmutter (Democratic)Zoe Lofgren (Democratic)Scott R. Tipton (Republican)Jenniffer González-Colón (Republican)Jason Crow (Democratic)Susie Lee (Democratic)Cathy McMorris Rodgers (Republican)Chellie Pingree (Democratic)Mike Levin (Democratic)

Health Subcommittee, Energy and Commerce Committee

Health

Related Bills

  • S 116-2477: National Commission on Scleroderma and Fibrotic Diseases Act of 2019
  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Advisory bodiesCongressional oversightGovernment studies and investigationsHealth programs administration and fundingHealth promotion and preventive careMedical researchMedical tests and diagnostic methodsMusculoskeletal and skin diseasesOrgan and tissue donation and transplantationResearch administration and fundingResearch and development